Found 13 matching trials
Lurasidone Extended Use Study
PHASE3This is an open-label continuation study designed to monitor the safety, to...
Location
Okanagan Clinical Trials
Major Depressive Disorder With Mixed Features
PHASE3Lurasidone HCl is a compound that is a candidate for the treatment of major...
Location
Birmingham Research Group
Major Depressive Disorder With Mixed Features - Extension
PHASE3Lurasidone HCl is a compound that is a candidate for the treatment of major...
Location
Birmingham Psychiatry Pharmaceutical Studies, Inc
Sleep Quality, Cognitive Performance, and Computerized Cognitive Training
N/APoor sleep quality is common in neuropsychiatric conditions and some of the...
Location
George West Mental Health Foundation, DBA Skyland Trail
Pediatric Open-Label Extension Study
PHASE3This is an open-label, 104-week, multicenter, extension study designed to e...
Location
Harmonex Neuroscience Research
18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar Disorder
PHASE4The goal of this project is to understand what causes bipolar disorder and ...
Location
Columbia University Medical Center
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
PHASE3This clinical study is designed to test the hypothesis that lurasidone is e...
Location
Synergy Escondido,710 East Grand Ave.
Lurasidone Pediatric Autism Study
PHASE3This is a randomized, double-blind, placebo-controlled study designed to ev...
Location
Harmonex Neuroscience Research
A Phase III Study of SM-13496 in Patients With Bipolar I Depression.
PHASE3The study evaluates the efficacy and safety of SM-13496 compared with place...
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
PHASE3Lurasidone HCl is a compound that is a candidate for the treatment of major...
Location
Birmingham Psychiatry Pharmaceutical Studies, Inc.